The FDA has approved the first all-oral, fixed-duration first-line regimen for treatment of chronic lymphocytic leukemia and ...
An investigational stent retriever device delivered successful revascularization in more than 85% of patients with primary distal vessel occlusion ischemic stroke at 24 hours, researchers reported at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results